BAGANBAZAR GRAPHEXPLORE · ANALYZE · GROW
Theme
LiveDesk
WorldBank of America spends $250 million a year on GLP-1 drugs for its employees, CEO saysWorldBOOK REVIEW: Half Lives — Exploring intimate-partner violence and migration with nuanced sensitivityWorldDIGITAL SOVEREIGNTY: State IT agency faces fork in the road on rehabilitation journeyWorldWORLD NEWS DAY OP-ED: A central bank investigation and the box of watermelon gumWorldANALYSIS: How the taxi industry wins when the state weakens
World/Source-attributed reporting
World DESK

Bank of America spends $250 million a year on GLP-1 drugs for its employees, CEO says

Employers have grappled with soaring demand for GLP-1 drugs such as Ozempic and Wegovy, which can cost thousands of dollars per patient annually.

Published Aug 17, 2026 · 1:12 AMOriginal source: Consumer News and Business Channel16 reads
Employers have grappled with soaring demand for GLP-1 drugs such as Ozempic and Wegovy, which can cost thousands of dollars per patient annually.
ORIGINAL SOURCE

Consumer News and Business Channel

This report is indexed by BAGANBAZAR GRAPH with its original publisher named and linked for readers.

Read at original outlet ↗
RELATED COVERAGE

More from this desk.